SCHEMBL4353465

SCHEMBL4353465

O=C(Oc1nccc2ccccc12)C(=O)Oc1nccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK5 Q9Y337 1/20 0.51
PLAU P00749 2/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
CYP2A6 P11509 1/20 0.46
F12 P00748 1/20 0.46
NCF1 P14598 1/20 0.46
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
NOS2 P35228 1/20 0.46
BACE1 P56817 1/20 0.46
TRPA1 O75762 1/20 0.45
LMNA P02545 1/20 0.45
CNR2 P34972 4/20 0.44
FFAR1 O14842 1/20 0.43
PLG P00747 1/20 0.42
SSTR1 P30872 1/20 0.41
SSTR4 P31391 1/20 0.41
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28855596 0.90 KLK5 (0.47) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL27220785 0.87 KLK5 (0.53) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL761986 0.87 KLK5 (0.50) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL5716801 0.86 KLK5 (0.49) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL523707 0.86 KLK5 (0.49) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL28198079 0.86 KLK5 (0.49) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL2230387 0.86 KLK5 (0.49) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL231952 0.84 KLK5 (0.51) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL28197980 0.83 KLK5 (0.47) KLK5PLAUNCOA3CYP2A6F12
SCHEMBL6859491 0.82 CNR2 (0.52) KLK5PLAUNCOA3CYP2A6F12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106924264-A Sigma ligands for preventing and/or treating postoperative pain 埃斯特韦实验室有限公司 2017-07-07 CN disclosed
EP-2099303-A1 THERAPEUTIC TETRAHYDROISOQUINOLINE-BASED COMPOSITIONS FOR CANCER THERAPY The University of Tennessee Research Foundation (US) 2009-09-16 EP disclosed
WO-2008064329-A1 THERAPEUTIC TETRAHYDROISOQUINOLINE-BASED COMPOSITIONS FOR CANCER THERAPY UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2008-05-29 WO disclosed